Metagenomi, Inc. Common Stock (MGX NASDAQ) stock market data APIs
$1.4743
0.01(0.7%)
as of February 20, 2026
Try our APIs with
free plan!
Metagenomi, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
Metagenomi Therapeutics, Inc. a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. Its genome editing toolbox includes nuclease-based genome editing, base editors, RNA-mediated integration, including prime editing, and DNA-mediated integration, such CRISPR-associated transposases. The company has a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop and commercialize investigational medicines using genome editing technologies; and a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited TCR-based therapeutic products exclusively in the field of treatment, prevention, or diagnosis of any human cancer. Metagenomi Therapeutics, Inc. was incorporated in 2016 and is headquartered in EmeryVille, California.
Prev. Close
1.4743
Open
1.4891
High
1.4992
Low
1.4627
52 wk Range
1.23-3.95
Market Cap
57 071 K
Shares Outstanding
37 547 K
Revenue
30 913 K
EPS
-0.55
Beta
0.521
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Metagenomi, Inc. Common Stock (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Metagenomi, Inc. Common Stock data using free add-ons & libraries
Get Metagenomi, Inc. Common Stock Fundamental Data
Metagenomi, Inc. Common Stock Fundamental data includes:
- Net Revenue: 30 913 K
- EBITDA: -86 791 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-11
- EPS/Forecast: -0.8
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Metagenomi, Inc. Common Stock News
New
Delta Lithium And 2 Other ASX Penny Stocks To Consider
As the Australian market embraces a "risk-on" sentiment, with precious metals and equity indices experiencing notable hikes, investors are keenly observing opportunities that align with current econom...
Undervalued Global Small Caps With Insider Buying In January 2026
As the global markets navigate a mixed landscape, small-cap and value stocks have emerged as leaders, with indices like the Russell 2000 and S&P MidCap 400 reaching all-time highs. This environment hi...
ASX Penny Stocks To Consider In December 2025
As the Australian market approaches the end of 2025, it is experiencing a slight dip, with some investors engaging in profit-taking ahead of the holiday season. Despite this minor downturn, opportunit...
Unveiling 3 Undervalued Asian Small Caps With Insider Buying
As Asian markets navigate a landscape marked by Japan's significant interest rate hike and China's mixed economic signals, small-cap stocks present intriguing opportunities amidst broader market fluct...
Get Metagenomi, Inc. Common Stock fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
